Skip to main
PRE

PRE Stock Forecast & Price Target

PRE Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Prenetics Global is a nutrition and longevity company with a strong focus on subscription-based revenue growth, highlighted by their impressive partnerships and recent $1 billion financing deal. While the company faces competition in the dietary supplements market, their use of AI technology for marketing and focus on customer retention puts them in a good position for success. However, it will be important for Prenetics to carefully manage customer acquisition and expenses to maintain their strong financial position and continue their growth trajectory.

Bears say

Prenetics Global is projected to have strong revenue growth, but their high S&M expenses at over 60% of revenue and customer LTV/CAC ratio of 3:1 indicate that their business model may not be sustainable in the long term. Additionally, the recent divestment of several subsidiaries may be a red flag for their overall financial health and stability.

PRE has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Prenetics Global Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Prenetics Global Ltd (PRE) Forecast

Analysts have given PRE a Strong Buy based on their latest research and market trends.

According to 4 analysts, PRE has a Strong Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $34.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $34.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Prenetics Global Ltd (PRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.